Literature DB >> 6817707

Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa.

J J Zuravleff, V L Yu, R B Yee, M K Zaphyr, W Diven, F B Taylor.   

Abstract

Correlation between in vitro and in vivo test results for synergy between carboxypenicillins and aminoglycosides against Pseudomonas aeruginosa is poor. Although the divalent cation content of culture media is known to affect aminoglycoside susceptibility testing for P. aeruginosa, this effect of divalent cations has not been examined for synergy testing of carboxypenicillin-aminoglycoside interaction against P. aeruginosa. The minimal inhibitory concentrations (MICs) of tobramycin and ticarcillin and the interaction of these drugs in combination were studied by a microtitration method for 36 strains of P. aeruginosa in Mueller-Hinton broth with varying supplements of calcium, magnesium, and zinc. The supplementation of Mueller-Hinton broth to 50 or 100 mg of calcium per liter had a significant effect in increasing the tobramycin MIC (P less than 0.01), as well as decreasing the degree of synergy between ticarcillin and tobramycin (P less than 0.01). Supplementation to 20 mg of magnesium per liter, 1.0 mg of zinc per liter, or both did not significantly affect tobramycin MIC or the interaction of tobramycin and ticarcillin. Supplementation to 50 or 100 mg of calcium per liter rendered any additional effect of magnesium and zinc on aminoglycoside MIC and aminoglycoside-carboxypenicillin interaction negligible. If these results for ticarcillin and tobramycin are confirmed for other carboxypenicillins and aminoglycosides, then the Mueller-Hinton broth used for P. aeruginosa aminoglycoside susceptibility and synergy testing may need to be supplemented only with calcium at a concentration of 50 mg/liter.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817707      PMCID: PMC185669          DOI: 10.1128/AAC.22.5.839

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.

Authors:  R C Ostenson; B T Fields; C M Nolan
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.

Authors:  V M Zimelis; G G Jackson
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

3.  Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro.

Authors:  M Sonne; E Jawetz
Journal:  Appl Microbiol       Date:  1969-06

4.  Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin.

Authors:  T I Nicas; R E Hancock
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

5.  Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

6.  Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.

Authors:  T P Felegie; V L Yu; L W Rumans; R B Yee
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).

Authors:  V L Yu; R M Vickers; J J Zuravleff
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

9.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

10.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

View more
  5 in total

Review 1.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 2.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.

Authors:  A W Chow; J Wong; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.

Authors:  A W Chow; J Wong; K H Bartlett; S D Shafran; H G Stiver
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Microtiter plate with built-in oxygen sensors: a novel approach to investigate the dynamics of Pseudomonas aeruginosa growth suppression in the presence of divalent cations and antibiotics.

Authors:  Wafa Almatrood; Ismini Nakouti; Glyn Hobbs
Journal:  Arch Microbiol       Date:  2022-05-04       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.